Literature DB >> 6356271

Yersinia enterocolitica: guidelines for serologic diagnosis of human infections.

E J Bottone, D J Sheehan.   

Abstract

In the United States the diagnosis of human infection due to Yersinia enterocolitica is usually achieved by recovery of the microorganism. Serology as a diagnostic adjunct has been used minimally because of the absence of sufficient guidelines for interpretation of agglutinin titers. The serologic response among three groups of subjects (control, febrile, and infected) was assessed, and the serologic diagnosis of Y. enterocolitica infection was found to be multifactorial. Except in well-circumscribed outbreaks, agglutinin titers must be interpreted on an individual basis, taking into consideration the patient's age and underlying disease and the antibiotics and immunosuppressive agents being administered. Other factors affecting interpretation are the prevalence of a given serogroup of Y. enterocolitica in the community, the nature of antigen used, and the awareness of prozone phenomena. Agglutinin titers in the range of 1:128 in previously normal, healthy individuals are suggestive of infection; negative or minimal titers (greater than or equal to 1:32) do not rule out yersiniosis in an infant or in an immunosuppressed patient. Serology appears to be a secondary alternative to the more definitive cultural endeavors for use in diagnosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356271     DOI: 10.1093/clinids/5.5.898

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  14 in total

1.  Relapsing yersinia infection.

Authors:  R C Read; R E Barry
Journal:  BMJ       Date:  1990-06-30

2.  Bacteriological and serological findings in a further case of transfusion-mediated Yersinia enterocolitica sepsis.

Authors:  E Strobel; J Heesemann; G Mayer; J Peters; S Müller-Weihrich; P Emmerling
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  Influence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with Yersinia-associated spondylarthropathy.

Authors:  J A Hoogkamp-Korstanje; J de Koning; J Heesemann; J J Festen; P M Houtman; P L van Oyen
Journal:  Infection       Date:  1992 Mar-Apr       Impact factor: 3.553

Review 4.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  The possible role of quinolones in yersiniosis.

Authors:  J A Hoogkamp-Korstanje
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  A young man with fever, splenomegaly, hepatic granulomas, and lymphocytic bone marrow infiltrates.

Authors:  P P Tak; P M Kluin; J A Hoogkamp-Korstanje; J de Koning; R Bieger; J C Kluin-Nelemans
Journal:  Ann Hematol       Date:  1993-02       Impact factor: 3.673

7.  Prevalence of Yersinia antibodies in blood donors.

Authors:  L Franzin; F Curti
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

8.  Functional defects in phagocytic cells following thermal injury. Application of flow cytometric analysis.

Authors:  R E Duque; S H Phan; J L Hudson; G O Till; P A Ward
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

9.  Human coproantibody secretory immunoglobulin A response to Yersinia species.

Authors:  K M Fletcher; C M Morris; M A Noble
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

10.  Incidence of Yersinia enterocolitica antibodies in patients with inflammatory joint diseases.

Authors:  V Tamburrino; R Monno; M A Valenza; R Numo
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.